Research team redefines the footprint of viral vector gene therapy

Building on a track record of developing adeno-associated viral (AAV) vectors as a groundbreaking clinical tool for gene therapy and gene editing, researchers report a more sensitive method for capturing the footprint of AAV vectors -- a broad range of sites where the vectors transfer genetic material.